Kirkland Represents Edding Group on Its Proposed Merger and Reverse Takeover With Genor Biopharma
October 08, 2024
October 08, 2024
CHICAGO, Illinois, Oct. 8 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis is representing Edding Group Company Limited, an integrated biopharmaceutical company focusing on research, development and commercialization of promising therapeutics in areas with considerable demand in the PRC, in connection with a proposed merger and reverse takeover with Genor Biopharma Holdings Limited, a Hong Kong-listed biopharmaceutical company under Chapter . . .
Kirkland & Ellis is representing Edding Group Company Limited, an integrated biopharmaceutical company focusing on research, development and commercialization of promising therapeutics in areas with considerable demand in the PRC, in connection with a proposed merger and reverse takeover with Genor Biopharma Holdings Limited, a Hong Kong-listed biopharmaceutical company under Chapter . . .